Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Clovis Oncology (CLVS)

Clovis Oncology Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLVS
DateTimeSourceHeadlineSymbolCompany
01/05/202321:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
14/04/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
06/04/202321:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
02/03/202313:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
16/02/202321:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
13/02/202311:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
10/02/202314:49Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLVSClovis Oncology Inc
12/01/202311:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
29/12/202214:36Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CLVSClovis Oncology Inc
13/12/202211:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
13/12/202211:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
12/12/202211:54Dow Jones NewsClovis Oncology Shares Fall Premarket After Bankruptcy FilingNASDAQ:CLVSClovis Oncology Inc
12/12/202205:18Business WireClovis Oncology Files for Chapter 11 Protection and Enters into Agreement to Sell FAP-2286NASDAQ:CLVSClovis Oncology Inc
16/11/202221:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLVSClovis Oncology Inc
09/11/202213:12Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CLVSClovis Oncology Inc
03/11/202220:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
03/11/202220:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
03/11/202220:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
03/11/202220:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
03/11/202220:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
27/10/202222:05Business WireClovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific RetreatNASDAQ:CLVSClovis Oncology Inc
17/10/202208:45Business WireClovis Oncology Highlights Updated LuMIERE Phase 1 Data of Targeted Radiotherapy Candidate FAP-2286 at the 35th Annual EANM CongressNASDAQ:CLVSClovis Oncology Inc
04/10/202221:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
03/10/202212:00Business WireTRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM MutationsNASDAQ:CLVSClovis Oncology Inc
21/09/202213:00Business WireClovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply AgreementNASDAQ:CLVSClovis Oncology Inc
13/09/202213:00Business WireClovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian CancerNASDAQ:CLVSClovis Oncology Inc
12/09/202212:55TipRanksClovis (NASDAQ:CLVS) Jumps After Rubraca Shows Progression-Free Survival in Ovarian CancerNASDAQ:CLVSClovis Oncology Inc
11/09/202215:30Business WireClovis Oncology’s Rubraca® (Rucaparib) as First-Line Maintenance Treatment Improves Progression-Free Survival in Women with Advanced Ovarian Cancer Across Disease Risk SubgroupsNASDAQ:CLVSClovis Oncology Inc
06/09/202221:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
06/09/202221:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLVSClovis Oncology Inc
 Showing the most relevant articles for your search:NASDAQ:CLVS